Home › Research › Prevention and risk
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston G, Huntley J, Liu KY, Costafreda SG, Selbæk G, Alladi S, Ames D, Banerjee S, Burns A, Brayne C, Fox NC, Ferri CP, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Nakasujja N, Rockwood K, Samus Q, Shirai K, Singh-Manoux A, Schneider LS, Walsh S, Yao Y, Sommerlad A, Mukadam N. The Lancet, 2024-08-10
Topic: Risk, prevention and care in population studies
Plain-language summary
This expert commission synthesized decades of population-level (observational) research to estimate how much dementia risk could theoretically be reduced by addressing 14 modifiable risk factors across life, from childhood education to late-life social isolation. It added two new factors since the 2020 report: high LDL cholesterol in midlife and untreated vision loss in later life. These are population attributable fraction estimates from observational data, not proof that fixing any single factor in any single person will prevent their dementia.
What this study adds
Evidence grade: Moderate
This is a pooled review. This commission estimated that roughly 45% of dementia cases worldwide are theoretically attributable to 14 combined modifiable risk factors and could potentially be prevented or delayed, adding high midlife LDL cholesterol and untreated vision loss since the 2020 report. These are population attributable fraction estimates from observational data, not proof that fixing any single factor in any single person will prevent their dementia.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., et al. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet.
Vancouver
Livingston G, Huntley J, Liu KY, Costafreda SG, Selbæk G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024.
BibTeX
@article{livingston2024-db2af7a5,
author = {Livingston, G. and Huntley, J. and Liu, K. Y. and Costafreda, S. G. and Selbæk, G. and Alladi, S. and Ames, D. and Banerjee, S. and Burns, A. and Brayne, C. and Fox, N. C. and Ferri, C. P. and Gitlin, L. N. and Howard, R. and Kales, H. C. and Kivimäki, M. and Larson, E. B. and Nakasujja, N. and Rockwood, K. and Samus, Q. and Shirai, K. and Singh-Manoux, A. and Schneider, L. S. and Walsh, S. and Yao, Y. and Sommerlad, A. and Mukadam, N.},
title = {{Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission}},
journal = {The Lancet},
year = {2024}
}
Built from the record alzhub holds for this paper, not looked up. This record has no DOI, so the citation leaves it out. Volume, issue and page numbers are not held in the record. The record names 27 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- 14 modifiable risk factors identified: less education, hearing loss, high LDL cholesterol, depression, traumatic brain injury, physical inactivity, diabetes, smoking, hypertension, obesity, excessive alcohol, untreated vision loss, social isolation, and air pollution
- Commission estimates roughly 45% of dementia cases worldwide are theoretically attributable to these combined modifiable factors and could potentially be prevented or delayed
- New in 2024: high midlife LDL cholesterol (~7% attributable) and untreated late-life vision loss (~2% attributable) added as risk factors
Why it matters
This commission estimated that roughly 45% of dementia cases worldwide are theoretically attributable to 14 combined modifiable risk factors and could potentially be prevented or delayed, adding high midlife LDL cholesterol and untreated vision loss since the 2020 report. These are population attributable fraction estimates from observational data, not proof that fixing any single factor in any single person will prevent their dementia.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Study designsystematic-review
- Effect size~45% of dementia cases theoretically attributable to combined modifiable factors; LDL cholesterol ~7% PAF; vision loss ~2% PAF
- Evidence strengthModerate
Limitations
PAF estimates are derived from observational meta-analyses and modeling assumptions (e.g. that factors are causal and fully modifiable), not a randomized trial; per this project's own research notes, the exact per-factor percentage breakdown was corroborated via secondary summaries rather than a direct read of the paywalled primary results table.
How this study scored 66/100
Published in a top-tier journal, and it is a systematic review of all the studies on the question. Scored zero for sample size, studied in people and indexed in PubMed because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 41 of the 62 points we could judge it on, which is 66 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 10 / 10 | Tier 1 — top-tier general journal (The Lancet) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 0 / 2 | No PubMed ID and no DOI — scores zero (not stated in the record — scored 0) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 41 / 62 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 41 of the 62 points we could judge it on is 66 out of 100. |
| Total | 66 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Prevention and risk from nearby years
Also tagged “prevalence”
1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.